Original Research

Published on 23 Dec 2021

Ultrasound-Guided Lauromacrogol Injection for the Treatment of Active Bleeding After Renal Biopsy

in Renal Pharmacology

Weizong Liu
Chunchun Jin
Qingshu Lian
Lifeng Xu
Zhanye Lin
Jianghao Lu
Xuehao Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.723634

1,604 views

Original Research

Published on 22 Dec 2021

Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways

in Renal Pharmacology

Liang-Pu Luo
Ping Suo
Li-Li Ren
Hong-Jiao Liu
Yamei Zhang
Ying-Yong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.800522

6,038 views
48 citations

Review

Published on 22 Dec 2021

Insulin-Like Growth Factor Binding Proteins in Kidney Disease

in Renal Pharmacology

Shuqiang Wang
Kun Chi
Di Wu
Quan Hong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.807119

8,403 views
30 citations

Review

Published on 21 Dec 2021

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease

in Renal Pharmacology

Zhonghong Yan
Guanran Wang
Xingyang Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.785375

9,055 views
17 citations

Original Research

Published on 21 Dec 2021

Zhen-Wu-Tang Induced Mitophagy to Protect Mitochondrial Function in Chronic Glomerulonephritis via PI3K/AKT/mTOR and AMPK Pathways

in Renal Pharmacology

Bihao Liu
Yiwen Cao
Dejuan Wang
Yuan Zhou
Peichun Zhang
Junbiao Wu
Junqi Chen
Jianguang Qiu
Jiuyao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.777670

9,220 views
34 citations

Original Research

Published on 21 Dec 2021

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting

in Renal Pharmacology

Yueh-Ting Lee
Chien-Ning Hsu
Chung-Ming Fu
Shih-Wei Wang
Chiang-Chi Huang
Lung-Chih Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.781379

4,752 views
8 citations

Original Research

Published on 21 Dec 2021

Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models

in Renal Pharmacology

Philipp Tauber
Frederick Sinha
Raffaela S. Berger
Wolfram Gronwald
Katja Dettmer
Michaela Kuhn
Maximilian Trum
Lars S. Maier
Stefan Wagner
Frank Schweda

Frontiers in Pharmacology

doi 10.3389/fphar.2021.761855

5,371 views
15 citations

Original Research

Published on 20 Dec 2021

High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease

in Renal Pharmacology

Meina Zou
Yanrong Chen
Zongji Zheng
Shuyue Sheng
Yijie Jia
Xiangyu Wang
Shijing Ren
Yanling Yang
Xiaomin Li
Wenhui Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.741087

4,018 views
10 citations

Original Research

Published on 16 Dec 2021

Immune Characteristics of IgA Nephropathy With Minimal Change Disease

in Renal Pharmacology

Huixian Li
Wanhong Lu
Haiyun Li
Xiaoling Liu
Xue Zhang
Liyi Xie
Ping Lan
Xiaoyang Yu
Yinjuan Dai
Xinfang Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2021.793511

4,136 views
7 citations

Original Research

Published on 13 Dec 2021

Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats

in Renal Pharmacology

Chunlan Ji
Yin Li
Yenan Mo
Zhaoyu Lu
Fuhua Lu
Qizhan Lin
Xusheng Liu
Chuan Zou
Yuchi Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.780924

5,376 views
22 citations

Review

Published on 10 Dec 2021

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease

in Renal Pharmacology

Shilu Luo
Ming Yang
Hao Zhao
Yachun Han
Na Jiang
Jinfei Yang
Wei Chen
Chenrui Li
Yan Liu
Chanyue Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.768100

8,226 views
26 citations

Original Research

Published on 10 Dec 2021

Maresin 1 Attenuates Lipopolysaccharide-Induced Acute Kidney Injury via Inhibiting NOX4/ROS/NF-κB Pathway

in Renal Pharmacology

Jiameng Li
Zhuyun Zhang
Liya Wang
Luojia Jiang
Zheng Qin
Yuliang Zhao
Baihai Su

Frontiers in Pharmacology

doi 10.3389/fphar.2021.782660

9,682 views
56 citations

Original Research

Published on 09 Dec 2021

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity

in Renal Pharmacology

Wojciech K. Jankiewicz
Scott D. Barnett
Anna Stavniichuk
Sung Hee Hwang
Bruce D. Hammock
Jawad B. Belayet
A. H. Khan
John D. Imig

Frontiers in Pharmacology

doi 10.3389/fphar.2021.744776

2,882 views
5 citations

Original Research

Published on 07 Dec 2021

Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney Disease

in Renal Pharmacology

Xinyu Wang
Jiaqing Xiang
Guixiao Huang
Lin Kang
Guangyan Yang
Han Wu
Kewei Jiang
Zhen Liang
Shu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.779652

4,355 views
12 citations

Mini Review

Published on 07 Dec 2021

Regulatory B Cell Therapy in Kidney Transplantation

in Renal Pharmacology

Sergio G. Garcia
Noelia Sandoval-Hellín
Marcella Franquesa

Frontiers in Pharmacology

doi 10.3389/fphar.2021.791450

3,345 views
8 citations

Original Research

Published on 03 Dec 2021

Knowledge Domain and Emerging Trends in Podocyte Injury Research From 1994 to 2021: A Bibliometric and Visualized Analysis

in Renal Pharmacology

Tongtong Liu
Liping Yang
Huimin Mao
Fang Ma
Yuyang Wang
Yongli Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.772386

7,269 views
54 citations

Navigation group

Articles

Ultrasound-Guided Lauromacrogol Injection for the Treatment of Active Bleeding After Renal Biopsy

Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways

Insulin-Like Growth Factor Binding Proteins in Kidney Disease

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease

Zhen-Wu-Tang Induced Mitophagy to Protect Mitochondrial Function in Chronic Glomerulonephritis via PI3K/AKT/mTOR and AMPK Pathways

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting

Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models

High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease

Immune Characteristics of IgA Nephropathy With Minimal Change Disease

Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease

Maresin 1 Attenuates Lipopolysaccharide-Induced Acute Kidney Injury via Inhibiting NOX4/ROS/NF-κB Pathway

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity

Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney Disease

Regulatory B Cell Therapy in Kidney Transplantation

Knowledge Domain and Emerging Trends in Podocyte Injury Research From 1994 to 2021: A Bibliometric and Visualized Analysis